Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Ethical Review in Granting Invention Patents to Human Embryonic Stem Cells in China—with the Patent Dispute over “the Nuclear Reprogramming Factor” as a Case